Two patients (9%) harboured a mutation of the FGFR3 gene (F386L); in both cases it was associated with a VHL1 mutation (1 cases also with a PTEN mutation) and each patient presented respectively the mutation both in the primary RCC and the corresponding metastasis and the clear cell and in the rhabdoid component. Here, VHL is linked to renal cell adenocarcinoma.